Abstract
In this study, acetone was used as a desolvating agent to prepare the curcumin-loaded egg albumin nanoparticles. Response surface methodology was employed to analyze the influence of process parameters namely concentration (5–15 %w/v) and pH (5–7) of egg albumin solution on solubility, curcumin loading and entrapment efficiency, nanoparticles yield and particle size. Optimum processing conditions obtained from response surface analysis were found to be the egg albumin solution concentration of 8.85 %w/v and pH of 5. At this optimum condition, the solubility of 33.57 %, curcumin loading of 4.125 %, curcumin entrapment efficiency of 55.23 %, yield of 72.85 % and particles size of 232.6 nm were obtained and these values were related to the values which are predicted using polynomial model equations. Thus, the model equations generated for each response was validated and it can be used to predict the response values at any concentration and pH.
Similar content being viewed by others
Abbreviations
- ANOVA:
-
Analysis of variance
- BSA:
-
Bovine serum albumin
- CV:
-
Coefficient of variation
- EAC:
-
Egg albumin concentration
- HSA:
-
Human serum albumin
- RSM:
-
Response surface methodology
References
Sharma RA, Gescher AJ, Steward WP (2005) Curcumin: the story so far. Eur J Cancer 41:1955–1968
Arnedo A, Espuelas S, Irache JM (2002) Albumin nanoparticles as carriers for a phosphodiester oligonucleotide. Int J Pharm 244(1–2):59–72
Elzoghby AO, Samy WM, Elgindy NA (2012) Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 157:168–182
Irache JM, Espuelas S (2006) In: Kumar CSSR (ed) Biological and pharmaceuticals nanomaterials. Nanotechnologies for the life sciences. Wiley, New York
Jun JY, Nguyen HH, Paik SYR, Chun HS, Kang BC, Ko S (2011) Preparation of size-controlled bovine serum albumin (BSA) nanoparticles by a modified desolvation method. Food Chem 127(4):1892–1898
Wang G, Siggers K, Zhang S, Jiang H, Xu Z, Zernicke RF, Matyas J, Uludağ H (2008) Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating. Pharm Res 25(12):2896–2909
Sokoloski TD, Royer GP (1984) In: Davis SS, Illum L, McVie JG, Tomlinson E (eds) Microspheres and drug therapy. Pharmaceutical, immunological and medical aspects. Elsevier, Amsterdam
Burger JJ, Tomlinson E, Mulder EMA, McVie JG (1985) Albumin microspheres for intra-arterial tumor targeting. I. Pharmaceutical aspects. Int J Pharm 23:333–344
Ovadia H, Carbone AM, Paterson PY (1982) Albumin magnetic microspheres: a novel carrier for myelin basic protein. Immunol Methods 53(1):109–122
Cummings J, Allan L, Smyth JF (1994) Encapsulation of mitomycin C in albumin microspheres alters pharmacokinetics, drug quinone reduction in tumor tissue and antitumor activity. Biochem Pharmacol 47:1345–1356
Burgess DJ, Davis SS (1988) Potential use of albumin microspheres as a drug delivery system. II. In vivo deposition and release of steroids. Int J Pharm 46:69–76
Tomlinson E, Burger JJ (1985) In: Wilder KJ, Green R (eds) Methods in Enzymology. Academic Press, Orlando
Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S, Kim H, Jon S, Chen X, Lee KC (2011) Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm 403:285–291
Weber C, Coester C, Kreuter J, Langer K (2000) Desolvation process and surface characterization of protein nanoparticles. Int J Pharm 194(1):91–102
Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D (2003) Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm 257(1–2):169–180
Li F-Q, Su H, Wang J, Liu J-Y, Zhu Q-G, Fei Y-B, Pan Y-H, Hu J-H (2008) Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting. Int J Pharm 349(1–2):274–282
Ko S, Gunasekaran S (2006) Preparation of sub-100-nm β-lacto globulin (BLG) nanoparticles. J Microencapsul 23(8):887–898
Lin W, Coombes AG, Davies MC, Davis SS, Illum L (1993) Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J Drug Target 1(3):237–243
Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK (2007) Curcumin phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330(1–2):155–163
Cortés-Rojasa DF, Oliveira WP (2012) Physicochemical properties of phytopharmaceutical preparations as affected by drying methods and carriers. Drying Technol 30(9):921–934
Aziz HA, Tan YTF, Peh KK (2012) Solubility of drugs in aqueous polymeric solution: effect of ovalbumin on microencapsulation process. AAPS PharmSciTech 13(1):35–45
Park EK, Lee SB, Lee YM (2005) Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 26(9):1053–1061
Weng W, Liu W, Lin W (2001) Studies on the optimum models of the dairy product Kou Woan Lao using response surface methodology. Asian Australas J Anim Sci 14(10):1470–1476
Haber A, Runyon R (1977) General statistics, 3rd edn. Addison-Wesley, Reading
Kratz F (2008) Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 132(3):171–181
Wilting J, Hart BJ, De Gier JJ (1980) The role of albumin conformation in the binding of diazepam to human serum albumin. Biochim Biophys Acta 626:291–298
Galindo-Rodriguez S, Allémann E, Fessi H, Doelker E (2004) Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res 21:1428–1439
Deveswaran R, Manavalan R, Madhavan V, Bharath S (2010) Formulation and evaluation of albumin microspheres containing aceclofenac. Evaluation 4(1):020
Schmidt RH (1981) In: El Pour A (ed) Protein functionality in foods. American Chemical Society, Washington
Jithan AV, Madhavi K, Madhavi M, Prabhakar K (2011) Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer. Int J Pharm Investig 1(2):119–125
Taheri ES, Jahanshahi M, Mosavian MTH (2012) Preparation, characterization and optimization of egg albumin nanoparticles as low molecular-weight drug delivery vehicle. Part Part Syst Charact 29:1–12
Paik SYR, Nguyen HH, Ryu J, Che JH, Kang TS, Lee JK, Song CW, Ko S (2013) Robust size control of bovine serum albumin (BSA) nanoparticles by intermittent addition of a desolvating agent and the particle formation mechanism. Food Chem 141:695–701
Acknowledgments
The authors are grateful to Department of Science and Technology, Govt. of India for their financial support of this study through INSPIRE Fellowship 2013.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aniesrani Delfiya, D.S., Thangavel, K. & Amirtham, D. Preparation of Curcumin Loaded Egg Albumin Nanoparticles Using Acetone and Optimization of Desolvation Process. Protein J 35, 124–135 (2016). https://doi.org/10.1007/s10930-016-9652-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-016-9652-3